March 23 (Reuters) - Amgen Inc:
* AMGEN RECEIVES POSITIVE CHMP OPINION RECOGNIZING THAT REPATHA (EVOLOCUMAB) PREVENTS HEART ATTACKS AND STROKES
* AMGEN INC - RECOMMENDED LABEL INCLUDES NEW INDICATION BASED ON REPATHA CARDIOVASCULAR OUTCOMES STUDY Source text for Eikon: Further company coverage: